These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 20960222)
1. Synthesis and characterization of a novel chitosan based E. coli cytosine deaminase nanocomposite for potential application in prodrug enzyme therapy. Yata VK; Ghosh SS Biotechnol Lett; 2011 Jan; 33(1):153-7. PubMed ID: 20960222 [TBL] [Abstract][Full Text] [Related]
2. Product release is rate-limiting in the activation of the prodrug 5-fluorocytosine by yeast cytosine deaminase. Yao L; Li Y; Wu Y; Liu A; Yan H Biochemistry; 2005 Apr; 44(15):5940-7. PubMed ID: 15823054 [TBL] [Abstract][Full Text] [Related]
3. Alanine-scanning mutagenesis reveals a cytosine deaminase mutant with altered substrate preference. Mahan SD; Ireton GC; Stoddard BL; Black ME Biochemistry; 2004 Jul; 43(28):8957-64. PubMed ID: 15248753 [TBL] [Abstract][Full Text] [Related]
4. Adenovirus mediated cytosine deaminase gene transduction and 5-fluorocytosine therapy sensitizes mouse prostate cancer cells to irradiation. Anello R; Cohen S; Atkinson G; Hall SJ J Urol; 2000 Dec; 164(6):2173-7. PubMed ID: 11061950 [TBL] [Abstract][Full Text] [Related]
5. Preparation and properties of hybrid monodispersed magnetic α-Fe2O3 based chitosan nanocomposite film for industrial and biomedical applications. Singh J; Srivastava M; Dutta J; Dutta PK Int J Biol Macromol; 2011 Jan; 48(1):170-6. PubMed ID: 21056054 [TBL] [Abstract][Full Text] [Related]
6. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model. You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of chitosan-g-poly(acrylamide)/ZnS nanocomposite for controlled drug delivery and antimicrobial activity. Gupta D; Singh D; Kothiyal NC; Saini AK; Singh VP; Pathania D Int J Biol Macromol; 2015 Mar; 74():547-57. PubMed ID: 25592841 [TBL] [Abstract][Full Text] [Related]
8. The structure of Escherichia coli cytosine deaminase. Ireton GC; McDermott G; Black ME; Stoddard BL J Mol Biol; 2002 Jan; 315(4):687-97. PubMed ID: 11812140 [TBL] [Abstract][Full Text] [Related]
9. 4-(Ethoxycarbonyl) phenyl-1-amino-oxobutanoic acid-chitosan complex as a new matrix for silver nanocomposite film: preparation, characterization and antibacterial activity. Srivastava R; Tiwari DK; Dutta PK Int J Biol Macromol; 2011 Dec; 49(5):863-70. PubMed ID: 21820467 [TBL] [Abstract][Full Text] [Related]
10. Role of glutamate 64 in the activation of the prodrug 5-fluorocytosine by yeast cytosine deaminase. Wang J; Sklenak S; Liu A; Felczak K; Wu Y; Li Y; Yan H Biochemistry; 2012 Jan; 51(1):475-86. PubMed ID: 22208667 [TBL] [Abstract][Full Text] [Related]
11. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Trinh QT; Austin EA; Murray DM; Knick VC; Huber BE Cancer Res; 1995 Nov; 55(21):4808-12. PubMed ID: 7585511 [TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization and evaluation of a biopolymeric gold nanocomposite with antimicrobial activity. Chamundeeswari M; Sobhana SS; Jacob JP; Kumar MG; Devi MP; Sastry TP; Mandal AB Biotechnol Appl Biochem; 2010 Jan; 55(1):29-35. PubMed ID: 19929854 [TBL] [Abstract][Full Text] [Related]
13. Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia. Fox ME; Lemmon MJ; Mauchline ML; Davis TO; Giaccia AJ; Minton NP; Brown JM Gene Ther; 1996 Feb; 3(2):173-8. PubMed ID: 8867865 [TBL] [Abstract][Full Text] [Related]
14. Well-dispersed chitosan/graphene oxide nanocomposites. Yang X; Tu Y; Li L; Shang S; Tao XM ACS Appl Mater Interfaces; 2010 Jun; 2(6):1707-13. PubMed ID: 20527778 [TBL] [Abstract][Full Text] [Related]
15. Multimodal image-guided enzyme/prodrug cancer therapy. Li C; Winnard PT; Takagi T; Artemov D; Bhujwalla ZM J Am Chem Soc; 2006 Nov; 128(47):15072-3. PubMed ID: 17117842 [TBL] [Abstract][Full Text] [Related]
16. Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administration. Koyama F; Sawada H; Fujii H; Hirao T; Ueno M; Hamada H; Nakano H J Exp Clin Cancer Res; 2000 Mar; 19(1):75-80. PubMed ID: 10840940 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of chitosan/ZnO nanoparticle composite membranes. Li LH; Deng JC; Deng HR; Liu ZL; Xin L Carbohydr Res; 2010 May; 345(8):994-8. PubMed ID: 20371037 [TBL] [Abstract][Full Text] [Related]
18. pH-induced fabrication of DNA/chitosan/alpha-ZrP nanocomposite and DNA release. Liu L; Zhang HT; Shen B; He W; Liu Y; Lu GY; Zhu JJ Nanotechnology; 2010 Mar; 21(10):105102. PubMed ID: 20154366 [TBL] [Abstract][Full Text] [Related]
19. The rheological behaviour and drug-delivery property of chitosan/rectorite nanocomposites. Wang X; Tang Y; Li Y; Zhu Z; Du Y J Biomater Sci Polym Ed; 2010; 21(2):171-84. PubMed ID: 20092683 [TBL] [Abstract][Full Text] [Related]
20. Mechanical and barrier properties of nanocrystalline cellulose reinforced chitosan based nanocomposite films. Khan A; Khan RA; Salmieri S; Le Tien C; Riedl B; Bouchard J; Chauve G; Tan V; Kamal MR; Lacroix M Carbohydr Polym; 2012 Nov; 90(4):1601-8. PubMed ID: 22944422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]